The marker study

Markers of endothelial activation and damage in haematological patients in relation to efficacy of transfusion support: a pilot study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON27980

Enrollment

Registered

2007-02-16

Start date

2007-04-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological patients

Interventions

None

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age > 18 years; 2. Hemato-oncological disease; 3. Sickle cell disease; 4. Informed consent

Exclusion criteria

Exclusion criteria: 1. Active cardiovascular disease; 2. Recent thrombo-embolism.

Design outcomes

Primary

Measure	Time frame
Efficacy of platelet transfusion or red blood cell exchange transfusion in hemato-oncological patients and sickle cell patients, respectively, in relation to several endothelial activation markers.	—

Contacts

Public ContactJ.L.H. Kerkhoffs

HagaHospital, Leyweg 275

J.Kerkhoffs@hagaziekenhuis.nl+31 (0)70 3592004

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)